NEDD9, a novel target of miR-145, increases the invasiveness of glioblastoma
about
Implications of miR cluster 143/145 as universal anti-oncomiRs and their dysregulation during tumorigenesisNEDD9/Arf6-dependent endocytic trafficking of matrix metalloproteinase 14: a novel mechanism for blocking mesenchymal cell invasion and metastasis of breast cancer.Preclinical and clinical studies of the NEDD9 scaffold protein in cancer and other diseasesNEDD9 crucially regulates TGF-β-triggered epithelial-mesenchymal transition and cell invasion in prostate cancer cells: involvement in cancer progressivenessOverexpression of Nedd9 is a prognostic marker of human gastric cancerHEF1 promotes epithelial mesenchymal transition and bone invasion in prostate cancer under the regulation of microRNA-145FBW7 suppression leads to SOX9 stabilization and increased malignancy in medulloblastomaMiR-9-3p augments apoptosis induced by H2O2 through down regulation of Herpud1 in glioma.Establishing reliable miRNA-cancer association network based on text-mining method.MicroRNA expression signatures determine prognosis and survival in glioblastoma multiforme--a systematic overview.MicroRNA-145: a potent tumour suppressor that regulates multiple cellular pathways.MicroRNA expression patterns in the malignant progression of gliomas and a 5-microRNA signature for prognosis.Transcriptional profiling provides insights into metronomic cyclophosphamide-activated, innate immune-dependent regression of brain tumor xenograftsLow MiR-149 expression is associated with unfavorable prognosis and enhanced Akt/mTOR signaling in glioma.Protumorigenic effects of mir-145 loss in malignant pleural mesothelioma.Coordination of self-renewal in glioblastoma by integration of adhesion and microRNA signaling.MiR-145 inhibits oral squamous cell carcinoma (OSCC) cell growth by targeting c-Myc and Cdk6.MiR-145 functions as a tumor-suppressive RNA by targeting Sox9 and adducin 3 in human glioma cells.Epigenetic modification of miR-141 regulates SKA2 by an endogenous 'sponge' HOTAIR in glioma.MicroRNA in Human GliomaThe Prognostic Role of NEDD9 and P38 Protein Expression Levels in Urinary Bladder Transitional Cell Carcinoma.Current progress for the use of miRNAs in glioblastoma treatment.Systematic review of protein biomarkers of invasive behavior in glioblastoma.New advances of microRNAs in glioma stem cells, with special emphasis on aberrant methylation of microRNAs.MicroRNA: potential biomarkers and therapeutic targets for allergic asthma?Downregulation of NEDD9 by apigenin suppresses migration, invasion, and metastasis of colorectal cancer cells.MicroRNA-145 suppresses cell proliferation, invasion and migration in pancreatic cancer cells by targeting NEDD9.Synthetic miR-145 Mimic Enhances the Cytotoxic Effect of the Antiangiogenic Drug Sunitinib in Glioblastoma.Molecular subtypes of pancreatic cancer based on miRNA expression profiles have independent prognostic value.Stress response of glioblastoma cells mediated by miR-17-5p targeting PTEN and the passenger strand miR-17-3p targeting MDM2.MicroRNA-145 inhibits the growth, invasion, metastasis and angiogenesis of neuroblastoma cells through targeting hypoxia-inducible factor 2 alpha.MicroRNA-145 downregulation associates with advanced tumor progression and poor prognosis in patients suffering osteosarcoma.MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1.Serum microRNA profiling in patients with glioblastoma: a survival analysis.Prognostic role of microRNA-145 in various human malignant neoplasms: a meta-analysis of 18 related studies.MicroRNA in Glioblastoma: An Overview.5-Hydroxymethylcytosine preferentially targets genes upregulated in isocitrate dehydrogenase 1 mutant high-grade glioma.Expression of stem cell-regulating miRNAs in oral cavity and oropharynx squamous cell carcinoma.miR-145 inhibits migration and invasion of glioma stem cells by targeting ABCG2.
P2860
Q26783563-BA90E97D-E6E3-4E8C-8450-2EDBE429886CQ27310099-E0F1095A-746A-45D1-9BD8-31B16F2BF968Q28085339-F313315A-E162-462B-AD54-4C27416A56F2Q28238097-90C3786A-1401-4314-AFA7-4B49418055BDQ28241557-365E4CDB-7233-4F1D-8989-DF065693A315Q28284329-3B5941E4-5319-43BA-9B9D-983D0CB605D2Q28391884-F05CE875-416B-4929-BC22-A061899024DBQ33590275-ABD0021B-CEC5-49AE-A2CE-7CBB1AEE435AQ33594058-D55E16EC-1F03-41D5-883F-5B7F9887FAC1Q34409620-9B07F8A7-D1B6-48D9-89D3-74E95F7EC0E3Q34571491-511622AD-CD6D-4CEE-9B12-AABDD736E58CQ35149598-F5489B19-F4C9-4E64-BBFC-502490AD4907Q35624661-146E2A08-BB84-449B-9E3E-C76B62AEB2E6Q36261690-4AEA8F40-5684-4079-BFB9-F3EC43696E06Q36394044-F02D0249-48F5-47DC-A6E9-4740BA3E5D04Q36785112-2AF7AFF9-556D-4948-AADD-C6CC8A3FEB68Q36922953-AA128722-BF2E-4CC7-8506-975463F33DC9Q37187706-692E801A-CA08-444E-B52F-FBCFE5822FE1Q37327566-C32173DA-5F72-4208-AFEC-A8C85ED0AE8DQ37420580-20BD1C0E-0D1C-4166-A0C6-0526CF103C4FQ37615021-4CFCB6EC-3105-449C-A91E-967FAB474FA0Q38102611-D30D8B3A-3C0E-4EFF-A651-88218DAE409EQ38165795-267197B7-010A-4570-8744-1808BECFF921Q38174477-2FF196DD-B859-4FB5-A6FF-83A71EED139EQ38259337-CFF478DB-DFDF-4896-BFEA-F54A789689D2Q38737800-1DE8FCC3-D12C-4CC0-AF18-EC1467AF3455Q38913574-8B3E1F72-13E9-45F3-B897-5AE45F7F80FAQ38922566-3967BB1B-FD52-4A53-B46A-E57E3A7B2F87Q38934494-8E3285F5-CB29-49C2-8803-BD8B68FE0C01Q39198008-00AC6471-95B8-4877-A98D-A154325F1E87Q39230154-1E46B6CD-0856-42CD-88D6-729DE2D8EDCCQ41901440-05176314-91E2-4773-94EC-603D731A86B2Q42123071-162A8F74-0462-4DF5-8009-C9BE3BAC94A2Q42317085-FC1D0CD7-5A10-4495-9DE8-405D39E67357Q43046143-DB8A5152-B1FA-499C-9A13-EB6988F3EDDDQ47142132-EB06A5B1-808C-4383-8704-391FC125F319Q50079530-51B8A1E0-8505-4ADC-BD12-3F9500FDC186Q53188581-6AAEC1D7-115E-4202-ACAB-441CC2C2FC08Q55460959-E872BC58-6C66-4C24-BCF2-6B68621E5D00
P2860
NEDD9, a novel target of miR-145, increases the invasiveness of glioblastoma
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
NEDD9, a novel target of miR-145, increases the invasiveness of glioblastoma
@ast
NEDD9, a novel target of miR-145, increases the invasiveness of glioblastoma
@en
NEDD9, a novel target of miR-145, increases the invasiveness of glioblastoma
@nl
type
label
NEDD9, a novel target of miR-145, increases the invasiveness of glioblastoma
@ast
NEDD9, a novel target of miR-145, increases the invasiveness of glioblastoma
@en
NEDD9, a novel target of miR-145, increases the invasiveness of glioblastoma
@nl
prefLabel
NEDD9, a novel target of miR-145, increases the invasiveness of glioblastoma
@ast
NEDD9, a novel target of miR-145, increases the invasiveness of glioblastoma
@en
NEDD9, a novel target of miR-145, increases the invasiveness of glioblastoma
@nl
P2093
P2860
P3181
P356
P1433
P1476
NEDD9, a novel target of miR-145, increases the invasiveness of glioblastoma
@en
P2093
Dimos Kapetis
Federica Pisati
Gaetano Finocchiaro
Maria Carmela Speranza
Marica Eoli
Paola Porrati
Véronique Frattini
P2860
P304
P3181
P356
10.18632/ONCOTARGET.547
P407
P577
2012-07-01T00:00:00Z